These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 428151)
1. Fibrinous pericarditis and fibrinolysis in chronic dialysis patients. Cochran M; Lawton S; Rowlands LM Clin Nephrol; 1979 Jan; 11(1):23-5. PubMed ID: 428151 [TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in Nigerian diabetics with renal insufficiency. Unuigbe EI; Famodu AA; Umunna CE Clin Hemorheol Microcirc; 2005; 32(1):13-7. PubMed ID: 15665422 [TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis. Deguchi K; Izumi K; Noguchi M; Yuwasaki E; Suzuki H; Mori Y; Deguchi A; Ohkubo I; Tsuda M; Wada H Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646 [TBL] [Abstract][Full Text] [Related]
4. Changes in fibrinolytic activity during the course of a single hemodialysis session. Kurz H; Lerner RG; Weseley S; Nelson JC Clin Nephrol; 1985 Jul; 24(1):1-4. PubMed ID: 4040447 [TBL] [Abstract][Full Text] [Related]
5. A new euglobulin clot lysis assay for global fibrinolysis. Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279 [TBL] [Abstract][Full Text] [Related]
12. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis. Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and therapeutic questions about pericarditis in patients under chronic hemodialysis]. Mako J; Lengyel M; Békassy S; Gaizler G; Kökény M; Nagy L; Hamvas A; Balogh B Orv Hetil; 1981 Feb; 122(8):447-52. PubMed ID: 7290689 [No Abstract] [Full Text] [Related]
14. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis]. Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852 [TBL] [Abstract][Full Text] [Related]
15. Use of a phosphorus-enriched hemodialysate to prevent hypophosphatemia in a patient with renal failure-related pericarditis. Emelife-Obi C; Chow MT; Qamar-Rohail H; Leehey DJ; Gandhi VC; Ing TS Clin Nephrol; 1998 Aug; 50(2):131-3. PubMed ID: 9725787 [TBL] [Abstract][Full Text] [Related]
17. Effects of breast cancer and mastectomy on fibrinolytic activity in African women. Famodu ES; Fakoya AA; Barhua TA; Osime CO; Egwaikhide E; Egbagbe EE; Olu-Edo AN; Osime EO Afr J Reprod Health; 2006 Dec; 10(3):114-9. PubMed ID: 17518138 [TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
19. Uremic pericarditis: a prospective echocardiographic and clinical study. Wray TM; Stone WJ Clin Nephrol; 1976 Jul; 6(1):295-302. PubMed ID: 954236 [TBL] [Abstract][Full Text] [Related]
20. Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide. Matika RW; Nielsen VG; Steinbrenner EB; Sussman AN; Madhrira M ASAIO J; 2014; 60(6):716-21. PubMed ID: 25232771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]